On November 5, students in the Master of Prosthetics & Orthotics (MPO) program through Northwestern’s Prosthetics-Orthotics Center constructed more than 50 braces for teddy bears gifted to pediatric patients at Ann & Robert H. Lurie Children’s Hospital.
Valsartan, an angiotensin II receptor blocker drug, delayed disease progression and improved cardiac structure and function in patients with early-stage hypertrophic cardiomyopathy, according to a recent clinical trial.
An interdisciplinary team of Northwestern Medicine investigators led by Karen Ridge, PhD, has been awarded a $14 million grant from the National Heart, Lung, and Blood Institute to study the mechanisms that promote lung tissue repair in patients with severe viral pneumonia.
Northwestern scientists and clinicians demonstrated their continued commitment to advancing knowledge and therapies for amyotrophic lateral sclerosis during the 11th annual Les Turner Symposium on ALS.
Northwestern Medicine investigators have discovered that a microtubule regulatory protein inhibits early HIV type 1 (HIV-1) infection.
Northwestern investigators have identified a novel approach to control the hierarchical assembly of protein pathways with DNA, which may facilitate the construction of synthetic protein materials.
Through the Robert J. Havey, MD Institute for Global Health, Feinberg faculty across disciplines are training investigators from Africa, many of whom are enrolled in Feinberg graduate programs, on how to effectively conduct research about diseases currently impacting their home countries.
Donald Lloyd-Jones, MD, ScM, chair of Preventive Medicine and the Eileen M. Foell Professor of Heart Research, and current president of the American Heart Association, recently testified before Congress in support of legislation that would improve cardiovascular health in the U.S.
Three first-year students in Feinberg’s Physician Assistant (PA) Program have been awarded scholarships from The National Health Service Corps (NHSC) Scholarship Program.
In one of two low-risk randomized clinical trials, financial incentives increased study participation, and the use of financial incentives in both trials were deemed not unethical, according to recent findings.